Select Biosciences are delighted to announce the inaugural World Congress dedicated to OncoProteomics will be held on the 27-28 April in South San Francisco. The top investigators applying proteomics to cancer research will be presenting their latest cutting edge work, providing a unique opportunity to delegates to network with the most senior researchers in the field.

Agenda sessions include:

- Alterations in the proteome in cancer

Keynote Speaker: Samir Hanash, Director, Fred Hutchinson Cancer Research Center

- Molecular diagnostics for cancer

Keynote Speaker: Gordon R. Whiteley, Director, Clinical Proteomics Reference Lab, NCI, Gaithersburg

- Protein biochips

Chaired by William E. Rich, CEO, Ciphergen

- Personalized therapies for cancer

Keynote Speaker: Jack A. Roth, Professor and Chairman, M. D. Anderson Cancer Center

For the full downloadable agenda (pdf) please visit www.OncoProteomicsCongress.com

Selected media partnerships are available for this event. For further information contact: Karen Saunders (ksaunders@selectbiosciences.com )

About Select Biosciences

www.SelectBiosciences.com

Select Biosciences Ltd. is focused on organizing specialist biomedical meetings. Experts from both academia and commerce present timely information from current research through to commercial implementation of new technologies.